Loading clinical trials...
Loading clinical trials...
A Randomised Controlled Multicentre Clinical Trial, Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) and Standard of Care Versus Standard of Care Alone in the Healing of Chronic Diabetic Foot Ulcers
Conditions
Interventions
Dual Layer Amniotic Membrane (DLAM). Artacent®
Locations
16
United States
Titan Research
Phoenix, Arizona, United States
New Hope Podiatry
Los Angeles, California, United States
Royal Research
Pembroke Pines, Florida, United States
Pharma Research Associates
Westchester, Florida, United States
Regional Infectious Disease and Infusion Center, Inc
La Grange, Georgia, United States
Hoosier Foot and Ankle
Fishers, Indiana, United States
Start Date
September 1, 2020
Primary Completion Date
March 1, 2022
Completion Date
March 31, 2023
Last Updated
November 4, 2022
Lead Sponsor
SerenaGroup, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions